Fix the antibiotics pipeline

Nature

Volumn 472, Issue 7341, 2011, Pages 32-

  Cooper, Matthew A ^a   Shlaes, David ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; HEALTH CARE COST; NOTE; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CLINICAL TRIALS, PHASE III AS TOPIC; DRUG DESIGN; DRUG DISCOVERY; DRUG INDUSTRY; DRUG RESISTANCE, BACTERIAL; FEDERAL GOVERNMENT; HUMANS; INTERNATIONAL COOPERATION; LEADERSHIP; MODELS, ECONOMIC; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 79953740494     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/472032a     Document Type: Note

References (3)

1. Mossialos, E. et al. Policies and Incentives for Promoting Innovation in Antibiotic Research (London School of Economics and Political Science, 2009).
2. Morel, C. M. & Mossialos, E. Br. Med. J. 340, c2115 (2010).
3. Report on the European Commission's Public Online Consultation Stakeholder Consultation on the Transatlantic Task Force on antimicrobial resistance available at http://go.nature.com/hqetfw